NCT01778751

Brief Summary

This study will determine whether Home Telehealth-based implementation of an evidence-based intervention targeting Veterans with persistent poorly-controlled diabetes can improve hemoglobin A1c, patient self-management, and comorbid depressive symptoms in this high-risk, high-cost population. If effective, this intervention (Advanced Comprehensive Diabetes Care) offers a feasible, sustainable, and generalizable approach to managing Veterans with persistent poorly-controlled diabetes, which can be implemented using only existing Home Telehealth services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for early_phase_1 diabetes

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 29, 2013

Completed
10 months until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 25, 2016

Completed
Last Updated

January 25, 2016

Status Verified

December 1, 2015

Enrollment Period

1 year

First QC Date

January 18, 2013

Results QC Date

November 3, 2015

Last Update Submit

December 16, 2015

Conditions

Keywords

Self-Management SupportDepressionHome Telehealth

Outcome Measures

Primary Outcomes (1)

  • Diabetes Control

    Hemoglobin A1c as measured at baseline, 3m, 6m

    Baseline, 3months, 6months

Secondary Outcomes (3)

  • Diabetes Self Care

    Baseline, 3m, 6m

  • Self-reported Medication Adherence

    Baseline, 3m, 6m

  • Depressive Symptoms

    Baseline, 3m, 6m

Study Arms (2)

Control

NO INTERVENTION

Veterans will receive diabetes educational materials and management per their primary provider

Intervention

EXPERIMENTAL

Veterans randomized to the intervention arm will be enrolled in the HT program, provided with standard telemonitoring equipment by HT nursing staff (current HT practice at DVAMC is use of the Health Buddy 3 device for patients with landline phones and the Cardiocom Interactive Voice Response System for patients with cell phones), and will receive the study intervention for 6 months. Veterans without depressive symptoms on baseline PHQ-9 assessment (PHQ-9 \< 10) will not initially be entered into the depressive symptom management component of the intervention, but will be monitored for new symptoms throughout the intervention.

Behavioral: Home Telehealth with Behavioral Education Component

Interventions

The primary effectiveness outcome for this study will be hemoglobin A1c. Secondary effectiveness outcomes will include measures of diabetes self-care, self-reported medication adherence, and depressive symptoms.

Intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans with type 2 diabetes managed for \> 1 year at an eligible site (Durham, Raleigh, Greenville, or Morehead City) will be eligible for enrollment.
  • We will identify Veterans with PPDM (defined as the presence of at least 2 A1c values of \> 9.0% during the past year with no readings of \< 9.0% despite ongoing medical care) by reviewing electronic medical records and soliciting referrals from primary physicians.

You may not qualify if:

  • telephone interaction
  • metastatic cancer
  • active psychosis documented in medical record
  • active alcohol or substance abuse
  • diagnosis of dementia
  • known pregnancy (patients becoming pregnant during the study will be withdrawn and referred to appropriate services)
  • documented seizure history
  • documented history of severe complications of hypoglycemia (such as coma or seizure)
  • documented refusal or inability to perform self-monitoring of blood glucose
  • ongoing use of warfarin with prior history of major bleeding event
  • Due to challenges with dose adjustment by phone, Veterans on continuous subcutaneous insulin infusion (insulin pumps) will not be eligible for this study.
  • Due to challenges with regulations regarding testing supplies pts will need to be taking insulin (a few patients had enrolled prior to this change.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Durham VA Medical Center, Durham, NC

Durham, North Carolina, 27705, United States

Location

Related Publications (1)

  • Crowley MJ, Edelman D, McAndrew AT, Kistler S, Danus S, Webb JA, Zanga J, Sanders LL, Coffman CJ, Jackson GL, Bosworth HB. Practical Telemedicine for Veterans with Persistently Poor Diabetes Control: A Randomized Pilot Trial. Telemed J E Health. 2016 May;22(5):376-84. doi: 10.1089/tmj.2015.0145. Epub 2015 Nov 5.

MeSH Terms

Conditions

Diabetes MellitusDepression

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehavior

Limitations and Caveats

* Single-center pilot study * Small, male Veteran population with type 2 diabetes * Uses VA-specific infrastructure, findings may not translate to other settings.

Results Point of Contact

Title
Dr Matthew J Crowley
Organization
Durham Veterans Affairs Medical Center

Study Officials

  • Matthew J Crowley, MD

    Durham VA Medical Center, Durham, NC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2013

First Posted

January 29, 2013

Study Start

December 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 25, 2016

Results First Posted

January 25, 2016

Record last verified: 2015-12

Locations